Current portfolio

MinervaX

MinervaX is a biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus.

  • Sector
    Healthcare
  • Country
    Denmark
  • Fund
    LSP 7
  • Entry
    2023
  • Web
0
EQT logo